U.S. Supreme Court — Lanton Law Blog

Latest Mifepristone Legal Debates Raise More Questions, Confusion for Health Care Professionals

Lanton Law speak with Pharmacy Times about the Supreme Court’s decision on Mifepristone.

healthcare, U.S. Supreme CourtRon LantonMay 9, 2023U.S. Supreme Court, mifepristone, Dobbs v. Jackson Women’s Health

Expert Discusses Long-Term Implications of Roe V. Wade Decision for Pharmacists, Contraception Access

In an interview with Pharmacy Times, Ron Lanton III, Esq, partner at Lanton Law, discussed the recent Supreme Court ruling on Dobbs v. Jackson Women’s Health and what this could mean for pharmacists. In the interview, Lanton said the decision leaves many things ambiguous, which will most likely result in litigation around the country in the coming weeks and months.

U.S. Supreme Court Blocks Texas Content Moderation Law Applicable to Social Media Companies

The United States Supreme Court issued a May 31, 2022 5-4 opinion found here that blocks a Texas law that prohibits large social media companies, from banning or removing users’ posts based on political viewpoints.

technology, U.S. Supreme Court, communicationsRon LantonJune 1, 2022NetChoice, Computer & Communications Industry Association, U.S. Supreme Court, HB 20, Texas

Pharmacy Celebrates Another Win Over PBMs in the 8th Circuit

This week the 8th Circuit issued a decision in the case of Pharmaceutical Care Management Association v. Wehbi, which supported North Dakota’s legislative actions to regulate pharmacy benefit managers (PBMs). PCMA v. Wehbi is the first case at the federal appellate level since the landmark Rutledge v. PCMA decision last year that upheld Arkansas law also regulating PBMs.

healthcare, pharmacy, pharmaceuticals, life sciences, pharmacy benefit manager, U.S. Supreme CourtRon LantonNovember 19, 2021Pharmaceutical Care Management Association v. Wehbi, Rutledge v. PCMA, Pharmacy Benefit Manager, pharmacy, U.S. Supreme Court

Oral Arguments Scheduled for North Dakota PBM Case

Oral arguments have been scheduled for September 1, 2021 at 2:00 PM CST for PCMA v. Wehbi. Earlier this year, the U.S. Supreme Court vacated this 8th Circuit case formerly known as Wilke v. PCMA.

U.S. Supreme Court, pharmacy, pharmaceuticalsRon LantonAugust 23, 2021PCMA v. Wehbi, PCMA, PBM, Pharmacy Benefit Manager, 8th Circuit, Rutledge v. PCMA, U.S. Supreme Court, pharmacy, law

U.S. Supreme Court Limits the FTC’s Ability to Obtain Restitution for Deceptive Practices

On April 22, 2021, Justice Breyer wrote the majority opinion for AMG CAPITAL MANAGEMENT, LLC, ET AL. v. FEDERAL TRADE COMMISSION, which was a shock to many consumer advocates where the Court ruled unanimously against the Federal Trade Commission (FTC).

U.S. Supreme Court, FTC, privacyRon LantonApril 23, 2021AMG Capital Management v. FTC, FTC, Federal Trade Commission, U.S. Supreme Court, privacy

PBM Lobby Has 8th Circuit Win Vacated & Remanded

The U.S. Supreme Court ruled in a February 22, 2021 decision against the Pharmaceutical Care Management Association (PCMA); the Washington D.C. based trade group that represents pharmacy benefit managers (PBMs).

healthcare, pharmaceuticals, pharmacy, LTC, Long term care pharmacy, pharmacy benefit manager, U.S. Supreme Court, specialty pharmacyRon LantonFebruary 24, 2021U.S. Supreme Court, Rutledge v. PCMA, Wilke v. PCMA, pharmacy, ERISA, North Dakota

Lanton Law quoted in Bloomberg Law Article

We were quoted in Bloomberg Law’s article titled “States Risk Losing Power to Regulate Pharmacy Drug Middlemen” by Lydia Wheeler. The article discusses the pros and cons of Rutledge v. PCMA, which is currently being debated at the Supreme Court.

healthcare, insurance, life sciences, Long term care pharmacy, LTC, pharmaceuticals, pharmacy, pharmacy benefit manager, prescription drug costs, regulation, CMS, U.S. Supreme CourtRon LantonDecember 8, 2020Rutledge v. PCMA, U.S. Supreme Court

Lanton Law Quoted in Law360 Article Titled "High Court PBM Case Could Be Turning Point In 20-Year Fight"

Lanton Law was again quoted in Law360’s article titled “High Court PBM Case Could Be Turning Point in 20-Year Fight.” The article can be found here.

healthcare, insurance, pharmaceuticals, pharmacy, pharmacy benefit manager, U.S. Supreme CourtRon LantonDecember 1, 2020Rutledge v. PCMA, PBM, pharmacy, U.S. Supreme Court

Lanton Law Follow Up Interview with Law360

Lanton Law had a follow up interview with Law360 regarding the Rutledge v. PCMA Supreme Court oral arguments on October 6, 2020.

healthcare, insurance, pharmaceuticals, pharmacy, pharmacy benefit manager, U.S. Supreme CourtRon LantonOctober 7, 2020Rutledge v. PCMA

Lanton Law Quoted in Law360 Article on Rutledge v. PCMA

Lanton Law was quoted in Law360’s article titled “High Court to Weight States’ Ability to Rein in Drug Middlemen,” which was written in response to current developments around the Rutledge v. PCMA case.

U.S. Supreme Court, healthcare, pharmacy, pharmacy benefit manager, insuranceRon LantonOctober 6, 2020Rutledge v. PCMA

Lanton Law Speaks with Pharmacy Times about U.S. Supreme Court Case Rutledge v. PCMA & Its Implication on Pharmacy Policy

Lanton Law was interviewed by Pharmacy Times on the implications of the October 6, 2020 U.S. Supreme Court case of Rutledge v. PCMA.

healthcare, government affairs, Medicare Part D, pharmaceuticals, pharmacy, pharmacy benefit manager, prescription drug costs, reimbursement, U.S. Supreme CourtRon LantonJuly 27, 2020Rutledge v. PCMA, U.S. Supreme Court, Kentucky Pharmacy Law, Georgia Pharmacy Law, PBM, Pharmacy Benefit Manager, reimbursement